Monobenzone 40% Cream

Monobenzone 40% Cream, commonly marketed internationally as Benoquin 40, is a potent topical depigmenting formulation containing monobenzone 40% w/w. It is intended for medical depigmentation rather than cosmetic skin whitening.

Monobenzone is the monobenzyl ether of hydroquinone and acts differently from ordinary cosmetic skin-lightening agents. It can produce irreversible loss of pigmentation, which is why monobenzone products require careful medical supervision and are generally associated with extensive vitiligo rather than routine hyperpigmentation treatment.

Important U.S. distinction: Historical FDA-approved Benoquin was 20% monobenzone, not 40%. The 40% formulations marketed internationally should not be represented as an FDA-approved U.S. 40% product.

Product Information

Product Name

Benoquin 40 Cream

Generic / Active Ingredient

Monobenzone

Strength

40% w/w

Amount Per Gram

400mg monobenzone per 1g cream

Typical Pack

100g for international 40% formulations

Dosage Form

Topical Cream

Route

External / Cutaneous

Drug Class

Topical Depigmenting Agent

Primary Medical Use

Final depigmentation in selected extensive vitiligo cases

Prescription

Prescription / medical supervision recommended

Product Category

Dermatological medicine

U.S. Regulatory Note

Historical FDA-approved Benoquin labeling is for 20% monobenzone

U.S. 40% Status

40% international formulations should not be described as FDA-approved U.S. Benoquin 40

Monobenzone 40% vs Benoquin 20%

This distinction is important for international SEO and product accuracy.

Benoquin 20% is the historical U.S. FDA-approved formulation.

Benoquin 40% / Monobenzone 40% Cream refers to a higher-strength international formulation marketed under the Benoquin name by certain manufacturers.

They are not interchangeable by label strength, and a 40% product should not be represented as the FDA-approved U.S. Benoquin 20% formulation.

Monobenzone vs Hydroquinone

Monobenzone and hydroquinone are chemically related but have very different clinical purposes.

Monobenzone is a strong depigmenting agent associated with permanent melanocyte loss.

Hydroquinone is generally used as a topical treatment to reduce melanin production in conditions involving localized hyperpigmentation and does not have the same intended permanent depigmentation role.

Monobenzone should therefore not be treated as simply a stronger version of hydroquinone.

Is Benoquin 40 a Cosmetic Skin-Lightening Cream?

No.

Monobenzone is not an ordinary cosmetic bleaching ingredient. Its purpose in medical treatment is permanent depigmentation in appropriately selected patients with extensive vitiligo.

Using high-strength monobenzone on normal skin purely for cosmetic lightening can result in unpredictable and potentially permanent pigment loss.

Important U.S. Regulatory Information

The historical FDA-approved Benoquin label identifies Benoquin Cream 20% (monobenzone) as a prescription depigmenting medicine indicated for final depigmentation in extensive vitiligo.

FDA documentation also states that the product was approved under NDA 008173. Later FDA materials note that the product was no longer manufactured or distributed and had been de-listed.

Therefore:

• Benoquin 20% is the historical U.S. FDA-approved formulation.
• Benoquin 40% should not be described as FDA-approved in the United States.
• International 40% formulations may be legally marketed in other countries under different regulatory frameworks.
• U.S. buyers should not assume that an imported 40% product has U.S. FDA approval.

Sun Protection After Depigmentation

Loss of melanin substantially reduces the skin's natural pigment protection.

Patients undergoing medical depigmentation therefore require appropriate protection from ultraviolet exposure and should follow the advice of their dermatologist or treating healthcare professional.

Sun exposure can also influence the visual appearance and durability of depigmented skin.

Product Quality and Authentication

For an international Monobenzone 40% / Benoquin 40 product, verify:

• Monobenzone concentration: 40% w/w
• Pack size: commonly 100g for listed 40% formulations
• Manufacturer identity
• Batch number
• Expiry date
• Full ingredient list
• Original sealed packaging
• Country-specific regulatory information
• Appropriate product documentation

Do not assume that products labelled Benoquin 40, Monobenzone 40, or Monobenzone Cream USP 40% are identical simply because the active ingredient and concentration appear similar.

Availability & Ordering

Search demand for this product includes Monobenzone 40% Cream USA, Benoquin 40 Cream USA, Monobenzone Cream USP 40%, Benoquin 40 Cream 100g, Monobenzone Cream UK, Monobenzone 40% Australia, Benoquin Cream UAE, Monobenzone 40 Germany, Monobenzone 40 Korea and Monobenzone 40 France.

Because the 40% formulation is not the historical FDA-approved U.S. Benoquin strength, international product listings should clearly distinguish 40% monobenzone formulations from the former U.S. Benoquin 20% product.

How it works

Monobenzone is a potent depigmenting agent that affects melanocytes, the pigment-producing cells responsible for melanin production.

Its precise mechanism is not completely understood, but topical monobenzone can increase melanin elimination and may result in destruction or loss of melanocytes. Because melanocyte loss can be permanent, depigmentation produced by monobenzone may also be permanent.

The FDA's historical Benoquin labeling specifically notes that monobenzone is capable of producing irreversible depigmentation.

Monobenzone is used medically for permanent depigmentation of normal skin surrounding areas affected by extensive vitiligo in appropriately selected patients.

Historical FDA labeling for Benoquin 20% specifies its use for final depigmentation in patients with disseminated idiopathic vitiligo affecting more than 50% of body surface area.

The purpose is to reduce remaining normal pigmentation so that extensive areas of skin have a more uniform appearance.

Monobenzone is not intended as a routine treatment for:

• Melasma
• Freckles
• Ordinary hyperpigmentation
• Post-inflammatory pigmentation
• Age spots
• Cosmetic skin whitening
• Normal skin lightening

Monobenzone is substantially more potent than ordinary cosmetic depigmenting products.

Potential concerns include:

• Permanent depigmentation
• Unpredictable spread of pigment loss
• Increased sensitivity to sunlight after depigmentation
• Skin irritation
• Allergic reactions
• Uneven or patchy pigmentation
• Psychological or cosmetic consequences of irreversible pigment loss

The historical FDA label specifically warns that Benoquin is not a cosmetic skin bleach and should not be used for conditions other than disseminated vitiligo.

Who Should Not Use Monobenzone 40% Cream?

Monobenzone should not be used casually or as a general-purpose whitening product.

It is particularly inappropriate for people seeking treatment for:

• Minor pigmentation differences
• Freckles
• Melasma
• Cosmetic skin whitening
• Localized dark spots
• Ordinary post-acne pigmentation

People with a history of sensitivity to monobenzone or other formulation ingredients should avoid the product unless a specialist determines otherwise.